Upgrade to SI Premium - Free Trial

Baird Downgrades Gilead Sciences (GILD) to Neutral

July 26, 2018 5:32 AM
Baird downgraded Gilead Sciences (NASDAQ: GILD) from Outperform to Neutral with a price target of $79.00.Analyst Brian Skorney comments "The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades

Next Articles